Liver Fibrosis and Cirrhosis
The Liver Fibrosis and Cirrhosis SIG is an interactive group of investigators focusing on the pathogenesis, diagnosis and treatment of liver fibrosis and outcomes research. This SIG aims to broaden our knowledge of the disease and foster collaborations in basic and translational/clinical studies of liver fibrosis and cirrhosis with a strong focus on extracellular matrix and hepatic stellate cell biology, as well as antifibrotic treatments and trials. The Liver Fibrosis and Cirrhosis SIG sponsors programs at the AASLD Annual Meeting, identifies emerging topics in fibrosis and cirrhosis research, and develops educational webinar programs.
SIG Leadership
- Chair
- Heather L. Francis, PhD, FAASLD
- Vice Chair
- Meena B. Bansal, MD, FAASLD
- Communication Lead
- Marko Groeger, PhD
- Education Lead
- Tatiana Kisseleva, MD, PhD
- Trainee Lead
- Rabab Ali, MBBS
- SIG Steering Committee Member
- Gianfranco Alpini, PhD, FAASLD
- Staff Liaisons
- Akuender Dot, MPH
- Julie Hoffman, MBA
- At-Large
- Leila Gobejishvili, PhD